HIV-associated dementia (HAD) is an important complication of the central nervous system
in patients who are infected with HIV-1. Although the incidence of HAD has markedly …

Macrophages are important target cells for the Human Immunodeficiency Virus Type I (HIV-
1) in vivo. Several studies have assessed the molecular biology of the virus in this cell type …

The release of microparticles from eukaryotic cells is a well-recognized phenomenon. We
demonstrate here that the chemokine receptor CCR5, the principal co-receptor for …

Parkinsonism secondary to viral infections is not an uncommon occurrence and has been
brought under the spotlight with the spread of severe acute respiratory syndrome …

A major obstacle in human immunodeficiency virus type 1 (HIV-1) eradication is the ability of
the virus to remain latent in a subpopulation of the cells it infects. Latently infected cells can …

Parkinson's disease is a debilitating neurological disorder characterized that affects 1–2% of
the adult population over 55 years of age. For the vast majority of cases, the etiology of this …

The availability of highly active antiretroviral therapies (HAART) has not eliminated HIV-1
infection of the central nervous system (CNS) or the occurrence of HIV-associated …

Neurodegeneration and dementia are common complications of AIDS caused by human
immunodeficiency virus type 1 (HIV-1) infection of the central nervous system. HIV-1 target …

We presently describe the full-length cloning and functional characterization of an HIV-1-
inducible gene, astrocyte elevated gene (AEG)-1. Additionally, a novel method is outlined for …

ABSTRACT HIV continues to be a global health crisis with more than 34 million people
infected worldwide (UNAIDS: Report on the Global AIDS Epidemic 2010, Geneva, World …